Breast cancer is not one disease, but a very diverse clinicopathological entity.

Compilation
Cesar A. Rodriguezoncologist at the University Hospital of Salamanca, emphasized the knowledge gained over the last 30 years about breast cancer, while making sure that this pathology is not a single disease,”“but these are very different clinicopathological entities with different therapeutic approaches.”

“This has led to the extremely rapid development of new, much more selective treatment strategies, meaning that today the treatment of a patient with this type of tumor becomes an almost individualized strategy.”Rodriguez explained this during his time on the campaign trail. Pink armchairspace AstraZenecawho wants to become a symbol promoting research and knowledge about the reality of breast cancer and the challenges that still have to be overcome.

“This has led to the extremely rapid development of new, much more selective treatment strategies, meaning that today, treating a patient with breast cancer is becoming an almost individualized strategy.”

For his part, the representative of the Spanish Federation of Breast Cancer (Fecma) Paula Gonzalezwho also participated in the campaign, highlighted the advances made in recent years in the fight against the disease. “They allow us to look at the diagnosis differently and give us the opportunity to perhaps see ourselves as possible long-livers because our ability to fight the disease has improved significantly.”– Gonzalez said.

However, a Fecma representative reminds that women living with this disease still demand “comprehensive care that also responds to all those needs that may depend on our context and the moment in life in which we find ourselves, as well as on the psychosocial sphere.”

“We must send a positive message that through research, new diagnostic methods and targeted therapies, our survival rate is increasing.”

President Spanish Association of Metastatic Breast Cancer (Aekmm), Pilar Fernandezwho took advantage of the speaker Pink armchair

talk about the specific situation of women suffering from this specific type of pathology, “the great unknown.”

“Metastatic breast cancer remains an incurable disease today. Yes, it is true, and we must send a positive message that through research, new diagnostic methods and targeted therapies, our survival rate is increasing.“, he pointed out.

Despite this, “30% of people diagnosed with breast cancer have metastatic disease, 6% have it from the onset of the disease, and the rest will develop it over the years.”

“Positivity does not cure, research and therapy do.”

Thus, Fernandez recalls that metastatic breast cancer causes more than 6,000 deaths per year, being the leading cause of death in women aged 35 to 50 years. For all this and since then Pink armchair of AstraZeneca explained that while she “loves the color pink”, breast cancer is often sweetened with messages of positivity and improvement, especially this October dedicated to raising breast cancer awareness: “Positivity does not cure, research and therapy do.”

“This chair is an open space in which we want to show that breast cancer is many different diseases, with completely different approaches, and in which we invite everyone who has close experience with this disease or wants to explore it to join. At AstraZeneca, we are committed to advancing precision medicine and collaborating with administrators to ensure that these advances reach patients, especially patients with metastatic breast cancer, as quickly as possible to make their disease chronic or permanently cured.“It’s over Marta Moreno, Director of Corporate Communications and Market Access, AstraZeneca, Spain.